• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IQN
Click for more information
0.00% 64.0¢

iQnovate Limited - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
IQN Application for Quotation of Additional Securities20/12/13
IQN Excercise of Options19/12/13
IQN Results from 2013 AGM03/12/13
IQN Addendum to 2013 Annual Report19/11/13
IQN 2013 AGM Proxy Form01/11/13
IQN Addendum to 2013 Annual Report27/10/13
IQN Notice of 2013 Annual General Meeting26/10/13
IQN 40510 NSX Annual Report 2013 (Price Sensitive) PRICE SENSITIVE27/09/13
IQN Preliminary Final Report (Price Sensitive) PRICE SENSITIVE13/09/13
IQN Approval to Commence Trading on GXG12/09/13
IQN Nominated Advisers Annual Statement to NSX27/08/13
IQN Listing on GXG Europe01/08/13
IQN IQNovate ADRs Piggyback Qualified in the USA14/06/13
IQN Response to Price Query - trade executed 5th of June 2013 07/06/13
IQN Price Query - trades executed on the 5th of June 2013 07/06/13
IQN Response to Price Query - trade executed 4th of June 201305/06/13
IQN Price Query - trade executed on the 4th of June 201305/06/13
IQN US Media Coverage23/05/13
IQN IQNovate Ltd Receives Quotation Clearance for OTC Pink13/05/13
IQN Change of Nominated Advisor22/03/13
IQN Half Yearly Financial Statements - 31 December 201215/03/13
IQN Private Placement Issue and Release of 1 year Escrow13/03/13
IQN Closure of Private Placement12/03/13
IQN IQNovate Ltd included in Mergent's manual in the USA18/12/12
IQN IQN Begins Trading in US thorugh Launch of ADRS17/12/12
IQN Updated Constitution07/12/12
IQN Results of 2012 AGM30/11/12
IQN Change in Director's Interests - G Syrmalis29/11/12
IQN Change in Director's Interests - G Syrmalis28/11/12
IQN Response from Issuer to Price Query dated 20th of November 201222/11/12
IQN Price Query for trades executed on the 20th of November 201222/11/12
IQN IQNovate to undertake private share placement30/10/12
IQN 2012 IQNovate Ltd Annual Report29/10/12
IQN Notice of 2012 Annual General Meeting29/10/12
IQN IQNovate signs agreement with Connect Biotech Pvte Ltd in India (Price Sensitive) PRICE SENSITIVE29/10/12
IQN Removal of requested trading halt.03/10/12
IQN Iqnovate seeking to list on OTC Pink Marketplace in USA (Price Sensitive) PRICE SENSITIVE03/10/12
IQN Withdrawal of Application for Listing on ASX (Price Sensitive) PRICE SENSITIVE03/10/12
IQN Iqnovate Ltd Requests Trading Halt (Price Sensitive) PRICE SENSITIVE02/10/12
IQN Application for Quotation of Additional Securities
20/12/13
IQN Excercise of Options
19/12/13
IQN Results from 2013 AGM
03/12/13
IQN Addendum to 2013 Annual Report
19/11/13
IQN 2013 AGM Proxy Form
01/11/13
IQN Addendum to 2013 Annual Report
27/10/13
IQN Notice of 2013 Annual General Meeting
26/10/13
IQN 40510 NSX Annual Report 2013 (Price Sensitive)
27/09/13PRICE SENSITIVE
IQN Preliminary Final Report (Price Sensitive)
13/09/13PRICE SENSITIVE
IQN Approval to Commence Trading on GXG
12/09/13
IQN Nominated Advisers Annual Statement to NSX
27/08/13
IQN Listing on GXG Europe
01/08/13
IQN IQNovate ADRs Piggyback Qualified in the USA
14/06/13
IQN Response to Price Query - trade executed 5th of June 2013
07/06/13
IQN Price Query - trades executed on the 5th of June 2013
07/06/13
IQN Response to Price Query - trade executed 4th of June 2013
05/06/13
IQN Price Query - trade executed on the 4th of June 2013
05/06/13
IQN US Media Coverage
23/05/13
IQN IQNovate Ltd Receives Quotation Clearance for OTC Pink
13/05/13
IQN Change of Nominated Advisor
22/03/13
IQN Half Yearly Financial Statements - 31 December 2012
15/03/13
IQN Private Placement Issue and Release of 1 year Escrow
13/03/13
IQN Closure of Private Placement
12/03/13
IQN IQNovate Ltd included in Mergent's manual in the USA
18/12/12
IQN IQN Begins Trading in US thorugh Launch of ADRS
17/12/12
IQN Updated Constitution
07/12/12
IQN Results of 2012 AGM
30/11/12
IQN Change in Director's Interests - G Syrmalis
29/11/12
IQN Change in Director's Interests - G Syrmalis
28/11/12
IQN Response from Issuer to Price Query dated 20th of November 2012
22/11/12
IQN Price Query for trades executed on the 20th of November 2012
22/11/12
IQN IQNovate to undertake private share placement
30/10/12
IQN 2012 IQNovate Ltd Annual Report
29/10/12
IQN Notice of 2012 Annual General Meeting
29/10/12
IQN IQNovate signs agreement with Connect Biotech Pvte Ltd in India (Price Sensitive)
29/10/12PRICE SENSITIVE
IQN Removal of requested trading halt.
03/10/12
IQN Iqnovate seeking to list on OTC Pink Marketplace in USA (Price Sensitive)
03/10/12PRICE SENSITIVE
IQN Withdrawal of Application for Listing on ASX (Price Sensitive)
03/10/12PRICE SENSITIVE
IQN Iqnovate Ltd Requests Trading Halt (Price Sensitive)
02/10/12PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.